Polio virus vax boosts glioblastoma survival

Around 21% of patients with advanced brain cancer treated with a modified polio vaccine were alive after three years, compared with 4% of patients with similar tumours who received standard therapies, new US research shows.

The findings, published online in the New England Journal of Medicine, are the latest update on an experimental cancer vaccine developed at the Duke Cancer Institute in Durham, North Carolina, for patients with glioblastoma.

For most patients whose